| 1alpha-Hydroxyalprazolam |
|---|
| 2alpha-Hydroxyalprazolam-d5 |
| 3Alprazolam |
| 4Clonazepam |
| 5Diazepam |
| 6Lorazepam |
| 7Nordiazepam |
| 8Nordiazepam-d5 |
| 9Oxazepam |
| 10Oxazepam-d5 |
| 11Temazepam |
| 12Temazepam-d5 |
search
Applications
Benzodiazepines from urine by Screen C on a ZB-Drug1
18055
Separation Mode: Application Specific
Application Specific
ZB-Drug-1
GC
Antiemetics,Anticonvulsants,Adjuvants, Anesthesia,Anti-Anxiety Agents,Anesthetics,Muscle Relaxants,Hypnotics and Sedatives,GABA Modulators
Forensics/Toxicology
Toxicology / Drug Screening / TDM
Therapeutic / Clinical
Analytes
Details
GC Conditions (App ID: 18055)
Column: |
Part No: |
Phase Name: ZB-Drug-1 |
Sample Notes: Analytes are 300ng/mL in urine derivatized with MTBSTFA
Sim ions:
(Quant ion*) D5-Nordiazepam (*332,334): Nordiazepam (*327,328,383): D5-Oxazepam (*462,519): Oxazepam (*457,513,459): D5-Temazepam (*362,288,390): Temazepam (*357,359,385): Lorazepam (*491,513,493): Clonazepam (*372,374,326):Diazepam (*256,283,221): Alprazolam (*279,308,204): D5-a-Hydroxyalprazolam (*386,388): a-Hydroxyalprazolam (*381,383,384) |
Similar Applications
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.